Alignment Healthcare, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD -40.24 M

Alignment Healthcare, Inc. EBITDA is USD -40.24 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -64.40% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Alignment Healthcare, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -113.05 M, a 4.22% change year over year.
  • Alignment Healthcare, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -108.47 M, a -25.40% change year over year.
  • Alignment Healthcare, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -145.40 M, a 300.36% change year over year.
  • Alignment Healthcare, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -36.32 M.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)